why choose us

First received: October 23, 2024

Clinical Trial: Pharmacokinetics, Dialysability and Safety of HRS-9231 in Healthy Volunteers and in Patients With Impaired Renal Function

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Contrast-Enhanced Magnetic Resonance Imaging Detection

Study Type: INTERVENTIONAL


Official Title: Pharmacokinetics (PK) Study of HRS-9231 Injection in Chinese Subjects With Renal Impairment and Normal Renal Function

Brief Summary: This is an open-label, non-randomized, parallel cohorts design, multicenter, single dose phase I study.The primary objectives are:To evaluate the pharmacokinetics (plasma and urine) profile of HRS-9231 following single intravenous injection (0.05 mmol/kg body weight) in patients with mild to severe renal impairment and in healthy volunteers with normal renal function used as reference.To assess dialysability of HRS-923 following a single intravenous injection (0.05 mmol/kg body weight) in patients with…

Read more